Literature DB >> 22006993

Neutralizing antibodies to hepatitis C virus in perinatally infected children followed up prospectively.

Jean-Christophe Meunier1, Jens Bukh, Giacomo Diaz, Pier-Angelo Tovo, Anna Maria Casadei, Isabella Quinti, Raffaele Iorio, Suzanne Emerson, Robert H Purcell, Patrizia Farci.   

Abstract

Little is known about the presence and role of neutralizing antibodies (NtAbs) in perinatal hepatitis C virus (HCV) infection. Using HCV pseudoparticles, NtAbs were studied longitudinally in 12 HCV-infected children with or without evidence of acute hepatitis during the first year of life. Broadly reactive NtAbs of maternal origin did not prevent vertical HCV transmission or progression to chronicity. NtAbs against homologous genotype or subtype appeared during the chronic phase and were more abundant and sustained in children with acute hepatitis. Cross-reactive NtAbs were present in both groups of children, but their appearance did not correlate with better control of viremia or HCV clearance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22006993      PMCID: PMC3218646          DOI: 10.1093/infdis/jir631

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1.

Authors:  Jean-Christophe Meunier; Ronald E Engle; Kristina Faulk; Ming Zhao; Birke Bartosch; Harvey Alter; Suzanne U Emerson; Francois-Loic Cosset; Robert H Purcell; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

2.  Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively.

Authors:  Patrizia Farci; Isabella Quinti; Stefania Farci; Harvey J Alter; Rita Strazzera; Elvia Palomba; Alessandra Coiana; Daniele Cao; Anna Maria Casadei; Ritarella Ledda; Raffaele Iorio; Angela Vegnente; Giacomo Diaz; Pier-Angelo Tovo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-17       Impact factor: 11.205

Review 3.  Neutralizing antibodies in hepatitis C virus infection.

Authors:  Mirjam-B Zeisel; Samira Fafi-Kremer; Isabel Fofana; Heidi Barth; Francoise Stoll-Keller; Michel Doffoel; Thomas-F Baumert
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

4.  Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation.

Authors:  Samira Fafi-Kremer; Isabel Fofana; Eric Soulier; Patric Carolla; Philip Meuleman; Geert Leroux-Roels; Arvind H Patel; François-Loïc Cosset; Patrick Pessaux; Michel Doffoël; Philippe Wolf; Françoise Stoll-Keller; Thomas F Baumert
Journal:  J Exp Med       Date:  2010-08-16       Impact factor: 14.307

5.  Neutralizing antibody response during acute and chronic hepatitis C virus infection.

Authors:  C Logvinoff; M E Major; D Oldach; S Heyward; A Talal; P Balfe; S M Feinstone; H Alter; C M Rice; J A McKeating
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-25       Impact factor: 11.205

6.  Maternal neutralizing antibody and transmission of hepatitis C virus to infants.

Authors:  Kimberly A Dowd; Ronald C Hershow; Sigal Yawetz; Philip Larussa; Clemente Diaz; Sheldon H Landesman; Mary E Paul; Jennifer S Read; Ming Lu; David L Thomas; Dale M Netski; Stuart C Ray
Journal:  J Infect Dis       Date:  2008-12-01       Impact factor: 5.226

7.  Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C.

Authors:  Daniel Steinmann; Heidi Barth; Bettina Gissler; Peter Schürmann; Mohammed I Adah; J Tilman Gerlach; Gerd R Pape; Erik Depla; Dirk Jacobs; Geert Maertens; Arvind H Patel; Geneviève Inchauspé; T Jake Liang; Hubert E Blum; Thomas F Baumert
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.

Authors:  Kimberly A Dowd; Dale M Netski; Xiao-Hong Wang; Andrea L Cox; Stuart C Ray
Journal:  Gastroenterology       Date:  2009-03-17       Impact factor: 22.682

9.  Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.

Authors:  Thomas von Hahn; Joo Chun Yoon; Harvey Alter; Charles M Rice; Barbara Rehermann; Peter Balfe; Jane A McKeating
Journal:  Gastroenterology       Date:  2006-12-03       Impact factor: 22.682

10.  Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C.

Authors:  Jan M Pestka; Mirjam B Zeisel; Edith Bläser; Peter Schürmann; Birke Bartosch; Francois-Loïc Cosset; Arvind H Patel; Helga Meisel; Jens Baumert; Sergei Viazov; Kay Rispeter; Hubert E Blum; Michael Roggendorf; Thomas F Baumert
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-28       Impact factor: 11.205

View more
  3 in total

Review 1.  Current progress in development of hepatitis C virus vaccines.

Authors:  T Jake Liang
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

Review 2.  Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progression.

Authors:  Pier-Angelo Tovo; Carmelina Calitri; Carlo Scolfaro; Clara Gabiano; Silvia Garazzino
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 3.  Pathogenesis of hepatitis C during pregnancy and childhood.

Authors:  Armelle Le Campion; Ariane Larouche; Sébastien Fauteux-Daniel; Hugo Soudeyns
Journal:  Viruses       Date:  2012-12-06       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.